Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Spiracur receives Canada license for SNaPWound Care System

Spiracur has received medical device license from Health Canada to sell SNaPWound Care System (Smart Negative Pressure) to treat patients suffering from chronic wounds.

Spiracur’s SNaP System’s design eliminates the electric or battery powered pump used to deliver negative pressure wound therapy (NPWT).

The device is indicated for removal of small amounts of exudates from chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic and pressure), surgically closed incisions, flaps and grafts.

Spiracur president and CEO Gary Restani said the Canadian marketplace offers Spiracur an opportunity to expand the presence of SNaP System to patients who benefit from a new device that improves their quality of life.